References
- Rossouw J E, Anderson G L, Prentice, et al. for the Women's Health Initiative Investigators. JAMA 2002; 288: 321–333
- Hersh A L, Stefanick M L, Stafford R S, et al. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291: 47–53
- Women's Health Initiative Steering Committee. Effects of conjugated equine estrogens in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 2004; 291: 1701–1712
- Rossouw J E, Prentice R L, Manson J E, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465–1477
- Manson J E, Allison M A, Rossouw J E, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591–2602
- Hodis H N. Commentary on the WHI Coronary-Artery Calcium Study of Manson et al. North American Menopause Society First to Know electronic newsletter 2007, June: 2–4, (reference 5)
- Gambacciani M, Ciaponi M, Genazzani A R. The HRT misuse and osteoporosis epidemic: a possible future scenario. Climacteric 2007; 10: 273–275
- Harman S M, Brinton E, Cedars M, et al. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 2005; 8: 3–12
- MacLennan A H, Sturdee D W. WHI, WHI, WHI?. Climacteric 2004; 7: 221–224
- Sturdee D W, MacLennan A H. The pendulum swings back. Climacteric 2006; 9: 73–74
- MacLennan A H, Sturdee D W. Long-term trials of HRT for cardioprotection – is this as good as it gets?. Climacteric 2007; 10: 1–4
- Pines A, Sturdee D W, Birkhäuser M H, et al. on behalf of the Board of the International Menopause Society. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 181–194
- Shapiro S. The Million Women Study: potential biases do not allow uncritical acceptance of the data. Climacteric 2004; 7: 3–7